Final overall survival analysis of the phase III randomized trial of chemotherapy with and without bevacizumab for advanced cervical cancer: A NRG Oncology-Gynecologic Oncology Group study Meeting Abstract
| Authors: | Tewari, K. S.; Sill, M. W.; Penson, R. T.; Huang, H.; Ramondetta, L. M.; Landrum, L. M.; Oaknin, A.; Reid, T. J.; Leitao, M. M.; Monk, B. J.; Michael, H. E. |
| Abstract Title: | Final overall survival analysis of the phase III randomized trial of chemotherapy with and without bevacizumab for advanced cervical cancer: A NRG Oncology-Gynecologic Oncology Group study |
| Meeting Title: | 39th ESMO Congress (ESMO 2014) |
| Journal Title: | Annals of Oncology |
| Volume: | 25 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2014 Sep 26-30 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2014-09-01 |
| Language: | English |
| ACCESSION: | WOS:000346901000005 |
| DOI: | 10.1093/annonc/mdu438.27 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA26 -- Source: Wos |
